General MedicationsORALGeneric
CIN-QUIN
QUINIDINE SULFATE
Standard Dose
300MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview CIN-QUIN is listed in Drugs@FDA under application 085297 (ANDA).
Marketing status: Discontinued Active ingredient QUINIDINE SULFATE Form and strength CAPSULE;ORAL - 300MG Sponsor SOLVAY Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview CIN-QUIN is listed in Drugs@FDA under application 085297 (ANDA). Marketing status: Discontinued Active ingredient QUINIDINE SULFATE Form and strength CAPSULE;ORAL - 300MG Sponsor SOLVAY Submission history See approval history documents.
Monitoring
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.